← Back to Clinical Trials
Recruiting EARLY_Phase 1 NCT07016555

NCT07016555 Burning Mouth Syndrome: Symptoms and Management

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07016555
Status Recruiting
Phase EARLY_Phase 1
Sponsor University of Massachusetts, Amherst
Condition Burning Mouth Syndrome
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-06-11
Primary Completion 2025-08-31

Trial Parameters

Condition Burning Mouth Syndrome
Sponsor University of Massachusetts, Amherst
Study Type INTERVENTIONAL
Phase EARLY_Phase 1
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-06-11
Completion 2025-08-31
Interventions
Oral cooling spray

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This research study aims to evaluate how an oral cooling spray, currently a commercial dietary supplement, impacts symptoms associated with burning mouth syndrome (BMS). This study will examine symptoms, frequency, and severity, along with other related side effects of BMS on food intake, enjoyment, and quality of life.

Eligibility Criteria

Inclusion Criteria: * Have buring mouth syndrome or experience oral burn * Live in the United States * At least 18 years old * Having been diagnosed or suspected diagnosis of burning mouth syndrome or suffer from chronic oral burn without any identifiable causative lesion * No tongue or cheek piercings * No history of cancer * No recent or scheduled dental treatment * No history of gum disease * No aversions to mint or hop extracts Exclusion Criteria: * Have recently undergone dental treatment in the last three months or have plans to undergo dental treatment (e.g., fillings, crowns, root canals, extractions, or other dental procedures) in the coming month. * Have started any new treatments for BMS in the last 3 months or have plans to start new treatments in the coming month.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology